Related Experiment Videos
Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary
Michael N Zairis1, Olga A Papadaki, Paraskevi K Psarogianni
1Department of Cardiology, Tzanio Hospital, Piraeus, Greece. zairis@hellasnet.gr
Insights
Persistent Chlamydia pneumoniae (Cp) infection, indicated by positive IgA titers, is linked to higher inflammation and adverse outcomes after coronary stenting (CS) in patients with unstable coronary syndromes.
Area of Science:
- Cardiology
- Infectious Disease
- Inflammation Research
Background:
- Inflammation plays a role in late prognosis after coronary stenting (CS).
- High preprocedural C-reactive protein (CRP) levels are associated with increased risk of late ischemic complications.
- Persistent Chlamydia pneumoniae (Cp) infection may contribute to this inflammation and adverse outcomes post-CS.
Purpose of the Study:
- To investigate the association between persistent Chlamydia pneumoniae (Cp) infection and late clinical outcomes after coronary stenting (CS).
- To evaluate the relationship between Cp infection, inflammation markers (CRP), and disease progression in patients undergoing CS.
Main Methods:
- A cohort of 483 patients with stable or unstable coronary syndromes underwent successful CS and were followed for 1 year.
- The study assessed a composite clinical endpoint, in-stent restenosis, and coronary artery disease progression.
- Preprocedural anti-Cp IgA and IgG titers, along with plasma CRP levels, were measured.
Main Results:
- Positive IgA anti-Cp titers correlated with high CRP levels in unstable coronary syndromes (P=.005), but not stable angina.
- Positive IgA titers were significantly associated with increased risk of the composite clinical endpoint (P=.04) and coronary artery disease progression (P<.001) in unstable patients.
- Neither IgA nor IgG titers predicted in-stent restenosis rates.
Conclusions:
- Persistent Chlamydia pneumoniae (Cp) infection may drive coronary inflammation.
- Cp infection portends an adverse late outcome in patients with unstable coronary syndromes undergoing CS.
- The findings highlight the potential impact of infectious agents on cardiovascular disease prognosis.
Background:
Previous studies have shown an incremental role of inflammation in late prognosis following coronary stenting (CS). In particular, high preprocedural levels of plasma C-reactive protein (CRP) have been related to increased hazard of late ischemic complications. Persistent Chlamydia pneumoniae (Cp) infection, detected by positive IgA anti-Cp titers, may be associated with this inflammatory process and portend a high risk of late adverse prognosis after CS.
Methods:
A total of 483 consecutive patients with either stable or unstable coronary syndromes were followed-up for 1 year after successful CS. The composite of cardiac death, myocardial infarction, rehospitalization for rest-unstable angina, and exertional angina, whichever occurred first, was the clinical end point. Additionally, the rate of in-stent restenosis and progression of coronary artery disease during this period were evaluated. Anti-Cp titers and plasma CRP levels were measured before the procedure.
Results:
Positive immunoglobulin A (IgA), but not positive immunoglobulin G (IgG), titers were significantly associated with high plasma CRP levels in patients with unstable coronary syndromes (P =.005), but not in those with stable angina (P =.7). Moreover, positive IgA titers were significantly related to increased risk of both the composite clinical end point (P =.04) and progression of coronary artery disease (P <.001) in patients with unstable coronary syndromes but not in those with stable angina. Neither positive IgA nor positive IgG titers were associated with the rate of in-stent restenosis.
Conclusions:
Persistent Cp infection may drive an inflammatory response in the coronary vasculature and portends an adverse late outcome after CS in patients with unstable coronary syndromes.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies